Frontiers in Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.4 | Q2 | 55.9% | 1.020 | Q2 | 84.3% |
| 2024 | 3.3 | Q2 | 62.6% | 1.075 | Q2 | 86.0% |
| 2023 | 3.5 | Q2 | 63.1% | 1.066 | Q2 | 87.1% |
| 2022 | 4.7 | Q2 | 68.4% | 1.138 | Q2 | 89.0% |
| 2021 | 5.7 | Q2 | 71.8% | 1.291 | Q1 | 91.1% |
| 2020 | — | — | 1.834 | Q1 | 94.7% | |
| 2019 | — | — | 1.654 | Q1 | 93.8% | |
| 2018 | — | — | 1.918 | Q1 | 94.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2234-943X
region
Western Europe
coverage
2011-2026